Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.64 - $1.21 $1,820 - $3,442
-2,845 Reduced 2.77%
99,763 $69,000
Q4 2022

Feb 14, 2023

BUY
$0.57 - $28.6 $58,486 - $2.93 Million
102,608 New
102,608 $74,000

About Virax Biolabs Group Ltd


  • Ticker VRAX
  • Exchange
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,374,100
  • Market Cap $20.4M
  • Description
  • Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid te...
More about VRAX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.